Posted at 13 Dec, 15:29h in Press Release by adialpharma 0 Comments 0 Likes Share Adial Pharmaceuticals Announces Planned Expansion of Lead Asset AD04 into Opioid Addiction Including Synthetic Opioids Such as Fentanyl
Sorry, the comment form is closed at this time.